HMGB2 and cancer: Interactome targets of HMGB1 or HMGB2 that have been identified in our Y2H study were previously found to be related to cancer hallmarks (Table S1 and Figure 1), and are also dysregulated in PCa, as confirmed by detection of changes in mRNA or protein levels.